225 related articles for article (PubMed ID: 30430668)
1. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
[TBL] [Abstract][Full Text] [Related]
2. [Cytology of body cavity fluids - established methods and new developments].
Engels M
Pathologe; 2022 Mar; 43(2):91-98. PubMed ID: 34994855
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
[TBL] [Abstract][Full Text] [Related]
4. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
5. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
Kaur K; Patel T; Patra S; Trivedi P
Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
[TBL] [Abstract][Full Text] [Related]
7. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
8. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
9. [Preparatory techniques of fluids and screening of malignant cells in effusions].
Nagumo S
Rinsho Byori; 1990 Nov; Suppl 87():191-200. PubMed ID: 2287088
[No Abstract] [Full Text] [Related]
10. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
[TBL] [Abstract][Full Text] [Related]
11. Individual specimen triage of effusion samples: an improvement in the standard of practice, or a waste of resources?
Filie AC; Copel C; Wilder AM; Abati A
Diagn Cytopathol; 2000 Jan; 22(1):7-10. PubMed ID: 10613964
[TBL] [Abstract][Full Text] [Related]
12. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
[TBL] [Abstract][Full Text] [Related]
13. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center.
Patel T; Patel P; Mehta S; Shah M; Jetly D; Khanna N
Diagn Cytopathol; 2019 Aug; 47(8):776-782. PubMed ID: 31091023
[TBL] [Abstract][Full Text] [Related]
14. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
Sundling KE; Cibas ES
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
[TBL] [Abstract][Full Text] [Related]
15. Utility of the thromboplastin-plasma cell-block technique for fine-needle aspiration and serous effusions.
Kulkarni MB; Desai SB; Ajit D; Chinoy RF
Diagn Cytopathol; 2009 Feb; 37(2):86-90. PubMed ID: 19021217
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review.
Harbhajanka A; Brickman A; Park JW; Reddy VB; Bitterman P; Gattuso P
Diagn Cytopathol; 2016 Sep; 44(9):742-7. PubMed ID: 27434129
[TBL] [Abstract][Full Text] [Related]
17. [Cytological variations observed in the malignant cells in body cavity fluids].
Matsuda M
Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
[No Abstract] [Full Text] [Related]
18. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
19. DNA Ploidy Analysis and Cell Block Immunohistochemistry in the Diagnosis of Malignant Effusions.
Puri M; Sen R; Gupta M; Kalra R; Bhargava S; Puri K
Acta Cytol; 2020; 64(3):256-264. PubMed ID: 31466063
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
